Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Gerussi

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Hepatology (Baltimore, Md.)|February 19, 2025
Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference NetworkRomée J A L M Snijders, Maciej K Janik, Meike Mund, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre StudyNatalie Uhlenbusch, Romée J A L M Snijders, Meike Mund, et al.
The Lancet. Gastroenterology & Hepatology|July 19, 2018
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response ScoreMarco Carbone, Alessandra Nardi, Steve Flack, et al.
Journal of Hepatology|May 25, 2021
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugsHeather J Cordell, James J Fryett, Kazuko Ueno, et al.
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Journal of Personalized Medicine|November 27, 2021
MEDTEC Students against Coronavirus: Investigating the Role of Hemostatic Genes in the Predisposition to COVID-19 SeverityClaudio Cappadona, Elvezia Maria Paraboschi, Nicole Ziliotto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of CholestasisVincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
Hepatology (Baltimore, Md.)|March 13, 2021
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.
JHEP Reports : Innovation in Hepatology|March 8, 2021
Real-world experience with obeticholic acid in patients with primary biliary cholangitisDaphne D'Amato, Antonio De Vincentis, Federica Malinverno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 6, 2022
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acidAntonio De Vincentis, Daphne D'Amato, Laura Cristoferi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|February 19, 2025
Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference NetworkRomée J A L M Snijders, Maciej K Janik, Meike Mund, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre StudyNatalie Uhlenbusch, Romée J A L M Snijders, Meike Mund, et al.
The Lancet. Gastroenterology & Hepatology|July 19, 2018
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response ScoreMarco Carbone, Alessandra Nardi, Steve Flack, et al.
Journal of Hepatology|May 25, 2021
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugsHeather J Cordell, James J Fryett, Kazuko Ueno, et al.
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Journal of Personalized Medicine|November 27, 2021
MEDTEC Students against Coronavirus: Investigating the Role of Hemostatic Genes in the Predisposition to COVID-19 SeverityClaudio Cappadona, Elvezia Maria Paraboschi, Nicole Ziliotto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of CholestasisVincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
Hepatology (Baltimore, Md.)|March 13, 2021
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.
JHEP Reports : Innovation in Hepatology|March 8, 2021
Real-world experience with obeticholic acid in patients with primary biliary cholangitisDaphne D'Amato, Antonio De Vincentis, Federica Malinverno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 6, 2022
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acidAntonio De Vincentis, Daphne D'Amato, Laura Cristoferi, et al.
Pageof 8